...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: $60m PP Question

Hi everyone, does anyone know where the $60m PP came from that is coming up around?  I saw itinerary Aureus' post first.

Also, if zenith did do a pre-ipo pp, how quickly can we see us doing an ipo?

Happy new year everyone, glad to see lifted energy between RVX and Zenith.

Share
New Message
Please login to post a reply